Contract Management:
DOD's Anthrax Vaccine Manufacturer Will Continue to Need Financial Assistance
T-NSIAD-00-140: Published: Apr 14, 2000. Publicly Released: Apr 14, 2000.
Additional Materials:
- Full Report:
Contact:
(202) 512-3000
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
Pursuant to a congressional request, GAO discussed the contractual relationship between the Department of Defense (DOD) and BioPort Corporation for production of the anthrax vaccine, focusing on: (1) the financial assistance DOD provided BioPort in 1999; and (2) additional financial assistance DOD is providing BioPort in 2000.
GAO noted that: (1) last year, DOD provided BioPort financial assistance so that the company would have sufficient operating capital to preclude disrupting, and possibly ending, the anthrax vaccine program; (2) among other things, DOD substantially increased the original contract price and provided an interest-free advance payment to BioPort of $18.7 million; (3) in providing the assistance, DOD believed the Food and Drug Administration (FDA) would approve the company's vaccine production processes in its renovated facilities by the end of 1999; (4) however, in November 1999, FDA reviewed the company's manufacturing processes and identified numerous deficiencies; (5) according to DOD officials, BioPort is now not expected to obtain FDA approval until the end of 2000; (6) the delay in obtaining FDA approval has caused BioPort to experience continuing financial problems; (7) recognizing the company's financial difficulties, DOD has taken a number of additional actions to help improve BioPort's financial situation; (8) in February 2000, DOD modified BioPort's contract to provide an additional amount of almost $12 million to, in part, hire technical assistance for obtaining FDA approval; (9) DOD also extended the schedule for BioPort to repay the interest-free advance payment and returned about $7.4 million that the company had repaid; (10) in March 2000, DOD notified BioPort that it wants BioPort to stop anthrax vaccine production for now; (11) this action reduces DOD's risk of paying for vaccine that the FDA may ultimately not approve and also allows BioPort to focus on obtaining FDA approval; (12) however, the company's financial condition is worsened because BioPort will no longer receive revenues from producing the vaccine; and (13) to mitigate the consequences of its actions, DOD intends to provide additional financial assistance to BioPort to sustain the production line.
Feb 26, 2021
-
Immigration Enforcement:
ICE Can Further Enhance Its Planning and Oversight of State and Local AgreementsGAO-21-186: Published: Jan 27, 2021. Publicly Released: Feb 26, 2021.
Feb 25, 2021
-
Airport Worker Screening:
TSA Could Further Strengthen Its Approach to Estimating Costs and Feasibility of Security MeasuresGAO-21-273: Published: Feb 25, 2021. Publicly Released: Feb 25, 2021.
Feb 23, 2021
-
Southwest Border Security:
Actions Are Needed to Address the Cost and Readiness Implications of Continued DOD Support to U.S. Customs and Border ProtectionGAO-21-356: Published: Feb 23, 2021. Publicly Released: Feb 23, 2021.
Feb 19, 2021
-
Countering Violent Extremism:
DHS Needs to Improve Grants Management and Data CollectionGAO-21-216: Published: Feb 1, 2021. Publicly Released: Feb 19, 2021.
Feb 12, 2021
-
Immigration Detention:
Actions Needed to Improve Planning, Documentation, and Oversight of Detention Facility ContractsGAO-21-149: Published: Jan 13, 2021. Publicly Released: Feb 12, 2021.
Feb 3, 2021
-
2018 Pacific Island Disasters:
Federal Actions Helped Facilitate the Response, but FEMA Needs to Address Long-Term Recovery ChallengesGAO-21-91: Published: Feb 3, 2021. Publicly Released: Feb 3, 2021.
Feb 2, 2021
-
Disaster Resilience:
FEMA Should Take Additional Steps to Streamline Hazard Mitigation Grants and Assess Program EffectsGAO-21-140: Published: Feb 2, 2021. Publicly Released: Feb 2, 2021.
Jan 28, 2021
-
U.S. Ports of Entry:
Update on CBP Public-Private Partnership ProgramsGAO-21-234R: Published: Jan 28, 2021. Publicly Released: Jan 28, 2021.
Jan 25, 2021
-
Southwest Border:
DHS and DOJ Have Implemented Expedited Credible Fear Screening Pilot Programs, but Should Ensure Timely Data EntryGAO-21-144: Published: Jan 25, 2021. Publicly Released: Jan 25, 2021.
Jan 21, 2021
-
Chemical Security:
Overlapping Programs Could Better Collaborate to Share Information and Identify Potential Security GapsGAO-21-12: Published: Jan 21, 2021. Publicly Released: Jan 21, 2021.
Looking for more? Browse all our products here